Invention Grant
- Patent Title: Quinolone derivative or pharmaceutically acceptable salt thereof
- Patent Title (中): 喹诺酮衍生物或其药学上可接受的盐
-
Application No.: US12293055Application Date: 2007-03-14
-
Publication No.: US08133882B2Publication Date: 2012-03-13
- Inventor: Yuji Koga , Takao Okuda , Susumu Watanuki , Takashi Kamikubo , Fukushi Hirayama , Hiroyuki Moritomo , Jiro Fujiyasu , Michihito Kageyama , Toshio Uemura , Jun Takasaki
- Applicant: Yuji Koga , Takao Okuda , Susumu Watanuki , Takashi Kamikubo , Fukushi Hirayama , Hiroyuki Moritomo , Jiro Fujiyasu , Michihito Kageyama , Toshio Uemura , Jun Takasaki
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc
- Current Assignee: Astellas Pharma Inc
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2006-073045 20060316
- International Application: PCT/JP2007/055040 WO 20070314
- International Announcement: WO2007/105751 WO 20070920
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/47 ; C07D215/22 ; C07F9/60

Abstract:
Provided are quinolone derivatives having a lower alkyl or cycloalkyl at the 1-position; —N(R0)C(O)-lower alkylene-CO2R0, lower alkylene-CO2R0, lower alkenylene-CO2R0, —O-lower alkylene-CO2R0, —O-(lower alkylene which may be substituted with —CO2R0)-aryl or —O-lower alkenylene-CO2R0 (wherein R0 is H or lower alkyl) at the 3-position; halogen at the 6-position; and amino group substituted with a substituent group having a ring structure at the 7-position, respectively, or pharmaceutically acceptable salts thereof. Pharmaceutical composition containing the quinolone derivatives and methods of using the compositions are provided.
Public/Granted literature
- US20090197834A1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Public/Granted day:2009-08-06
Information query